# Boston Scientific Embolic Protection, Inc. (EPI): A Carotid Stenting Trial for High-Risk Surgical Patients (BEACH)

> **NCT00316108** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 747 (actual)

## Conditions studied

- Carotid Artery Diseases
- Stroke
- Cerebral Arteriosclerosis

## Interventions

- **DEVICE:** WALLSTENT® Endoprosthesis™

## Key facts

- **NCT ID:** NCT00316108
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2005-05
- **Final completion:** 2007-11
- **Target enrollment:** 747 (ACTUAL)
- **Last updated:** 2014-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00316108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00316108, "Boston Scientific Embolic Protection, Inc. (EPI): A Carotid Stenting Trial for High-Risk Surgical Patients (BEACH)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00316108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*